Lactobacillus and Bifidobacterium strains are the most-commonly-used probiotics and are thought to affect immune function. Many welldesigned studies have provided evidence for the use of these strains in managing gastrointestinal disorders (1) , prevention of atopy in infants (2) and also colon cancer in men (3) . The potential immunological effects of probiotics in healthy individuals has been cited (4) . The aim of the present study was to determine the ability of Lactobacillus salivarius UCC 118 to colonize the large intestine, modify total gut microbiota composition and measure its effects on a number of immunological markers.
